Dr. Hanny Al-Samkari is the Peggy S. Blitz Endowed Chair in Hematology/Oncology at the Massachusetts General Hospital and an Associate Professor of Medicine at Harvard Medical School. He is a classical hematologist and NIH-funded clinical investigator and clinical trialist. He also serves as Co-Director the MGH Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence. His clinical and research interests are in hemostasis, thrombosis and hemolysis, with focuses in HHT, immune thrombocytopenia, and hemolytic anemias. As a clinical investigator, Dr. Al-Samkari is an internationally recognized expert in the clinical development of novel therapeutics for these disorders and serves as the lead principal investigator for multiple ongoing clinical trials. He is the emeritus Executive Editor of Hematology: The ASH Education Program, an American Society of Hematology peer-reviewed publication, and a current Associate Editor of the Journal of Thrombosis and Haemostasis, the flagship journal of the International Society on Thrombosis and Haemostasis. He has published over 180 peer-reviewed manuscripts. His original research has been featured in The New England Journal of Medicine, The Lancet, Annals of Internal Medicine and Blood, among other top peer-reviewed journals in hematology and medicine.

Dr Julie Curtin is a dual trained clinical and laboratory Haematologist at The Children's Hospital at Westmead. She has extensive experience in the diagnosis and management of children with Sickle Cell Disease. Dr Curtin has chaired the HGSA Working Group on Newborn Screening for Sickle Cell disease since 2025.

Dr Meg Wall is a Haematologist and Genetic Pathologist, based at Victorian Clinical Genetics Services in Parkville, Melbourne. Alongside over 15 years’ experience in cytogenetics, Meg has co-authored more than 70 journal articles and two book chapters in the fields of genetics, cancer genetics and haematology.

Dr Niles Nelson is a Consultant Haematologist and Supervising Pathologist for Tasmania’s statewide haematology genomics service.

Dr Peter Bradbeer is a Paediatric and Laboratory Haematologist at Starship Children's Health and LabPlus in Auckland. His clinical interests include Thrombosis and Haemostasis.

Molecular Haematologist with special interest in the genomics of myeloid disorders. Background of research in the genomics of red cell development and biology and red cell disorders including haemoglobinopathies.